Last reviewed · How we verify
penpulimab combined with anlotinib
penpulimab combined with anlotinib is a Small molecule drug developed by Tang-Du Hospital. It is currently FDA-approved.
At a glance
| Generic name | penpulimab combined with anlotinib |
|---|---|
| Sponsor | Tang-Du Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma (PHASE2)
- A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). (PHASE1)
- Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma (PHASE2)
- A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma (PHASE2)
- Neoadjuvant Therapy for Locally Advanced Rectal Cancer (EARLY_PHASE1)
- Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy (PHASE2)
- Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma (PHASE2)
- Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- penpulimab combined with anlotinib CI brief — competitive landscape report
- penpulimab combined with anlotinib updates RSS · CI watch RSS
- Tang-Du Hospital portfolio CI
Frequently asked questions about penpulimab combined with anlotinib
What is penpulimab combined with anlotinib?
penpulimab combined with anlotinib is a Small molecule drug developed by Tang-Du Hospital.
Who makes penpulimab combined with anlotinib?
penpulimab combined with anlotinib is developed and marketed by Tang-Du Hospital (see full Tang-Du Hospital pipeline at /company/tang-du-hospital).
What development phase is penpulimab combined with anlotinib in?
penpulimab combined with anlotinib is FDA-approved (marketed).